JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

493 Wed, 8/1/2012, 10:30 AM - 12:20 PM CC-Room 25B
Bayesian Applications in Clinical Trial Safety Assessment — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Haijun Ma, Amgen, Inc.
Chair(s): Haijun Ma, Amgen, Inc.
10:35 AM Recent Developments of Bayesian Meta-Analysis for Safety Evaluation in Randomized Clinical Trials Karen Price, Eli Lilly and Company
10:55 AM Identifying Potential Adverse Events Dose-Response Relationships via Bayesian Indirect and Mixed Treatment Comparison Models Haoda Fu ; Karen Price, Eli Lilly and Company ; Mary E. Nilsson, Eli Lilly and Company ; Stephen J. Ruberg, Eli Lilly and Company
11:15 AM Bayesian Meta Experimental Design: Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes H. Xia, Amgen, Inc. ; Joseph Ibrahim, The University of North Carolina at Chapel Hill ; Ming-Hui Chen, University of Connecticut ; Thomas Liu, Amgen, Inc.
11:35 AM Applications of Bayesian Model Selection for Clinical Safety Data Bradley McEvoy, FDA/CDER ; Rajesh R Nandy, University of California at Los Angeles ; Ram C. Tiwari, FDA/CDER/OTS/OB
11:55 AM Discussant: George Rochester, FDA
12:15 PM Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.